NASDAQ:NOVS Novus Capital (NOVS) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free NOVS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$16.87▼$37.6452-Week Range N/AVolume10.17 million shsAverage Volume370,842 shsMarket Capitalization$842,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Novus Capital alerts: Email Address Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy About Novus Capital Stock (NASDAQ:NOVS)Novus Capital Corporation is a blank check company. The company was founded in 2020 and is based in Indianapolis, Indiana.Read More Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy NOVS Stock News HeadlinesMarch 21, 2024 | markets.businessinsider.comEledon Pharmaceuticals: A Buy Rating on Breakthrough Organ Transplant SolutionsMarch 14, 2024 | markets.businessinsider.comBuy Rating Affirmed for Energy Vault Holdings Amidst Progress and Positive Outlook Despite Short-Term SetbacksApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 13, 2024 | bizjournals.comCary mansion sale price jumps to $9.6 millionMarch 13, 2024 | markets.businessinsider.comGoldman Sachs Sticks to Its Sell Rating for Energy Vault Holdings (NRGV)February 21, 2024 | msn.comDelayed (again): Why hasn’t downtown Durham Y broken ground? Here’s the answer.February 15, 2024 | msn.comAbstract Tech continues its support for Britain's Got Startups event seriesFebruary 14, 2024 | tmcnet.comLeaseWorks Hosts First Digital Transformation Innovation Summit During Airline Economics WeekApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 14, 2024 | msn.comAbstract Tech continues it's support for Britain's Got Startups event seriesFebruary 13, 2024 | msn.comBritian's Got Startups event series extended following 2023 successJanuary 26, 2024 | msn.comNewest mixed-use luxury residential coming to Downtown DurhamJanuary 16, 2024 | fool.com.auIf you'd put $20,000 in this ASX mining stock 13 months ago, you'd have $300,000 nowJanuary 8, 2024 | msn.comSEI Investments (SEIC) Gains From Buyouts Despite Cost WoesDecember 2, 2023 | reuters.comVietJet, Novus Aviation Capital to establish aircraft financing and leasing firmNovember 17, 2023 | msn.comKapitalo planeja abrir escritório em Nova York: FontesNovember 16, 2023 | msn.comNovo Nordisk Eyes Another Breakout As Weight-Loss Battle ContinuesOctober 31, 2023 | nasdaq.comRBC Capital Maintains Sunnova Energy International (NOVA) Outperform RecommendationOctober 30, 2023 | msn.comThere is potential for a year-end rally, says Virtus Investment's Joe TerranovaOctober 24, 2023 | msn.comNovo Nordisk: Growing To Potentially Become The First Trillion-Dollar European ChampionOctober 3, 2023 | msn.comObesity Drug Wegovy's Triumph to Catapult Novo Holdings In Golden Era Of Wealth BoostOctober 2, 2023 | msn.comThere is no fundamental catalyst for yields to fall in Q4, says Virtus Investment's Joe TerranovaSeptember 28, 2023 | marketwatch.comNovo Integrated Sciences' Shares More Than Double on $1B Funding DealSeptember 28, 2023 | marketwatch.comNovo Integrated Sciences to Get $1B in FundingSeptember 27, 2023 | msn.comSunnova's debt financing is 'wrong strategy,' Guggenheim analyst saysSeptember 22, 2023 | msn.comNovo Holdings, Gurnet Point close $462 million acquisition of Paratek PharmaceuticalsSeptember 18, 2023 | bizjournals.com2023 Inno Fire Awards, Top Funding Rounds: NovasentaSee More Headlines Receive NOVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novus Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural Production - Crops Sub-IndustryN/A Current SymbolNASDAQ:NOVS CUSIPN/A CIKN/A Webnovuscapitalcorporation.com Phone317-590-6959FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio10.48 Quick Ratio10.48 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares12,650,000Free FloatN/AMarket Cap$842,000.00 OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Larry M. Paulson (Age 67)CEO & Director Mr. Vincent Donargo (Age 60)Chief Financial Officer Key CompetitorsEdible GardenNASDAQ:EDBLAfrican AgricultureNASDAQ:AAGRRiceBran TechnologiesNASDAQ:RIBTSave FoodsNASDAQ:SVFDNuZeeNASDAQ:NUZEView All Competitors NOVS Stock Analysis - Frequently Asked Questions What is W. Lance Anderson's approval rating as Novus Capital's CEO? 6 employees have rated Novus Capital Chief Executive Officer W. Lance Anderson on Glassdoor.com. W. Lance Anderson has an approval rating of 87% among the company's employees. What other stocks do shareholders of Novus Capital own? Based on aggregate information from My MarketBeat watchlists, some companies that other Novus Capital investors own include Verizon Communications (VZ), Utz Brands (UTZ), SPDR S&P 500 ETF Trust (SPY), NVIDIA (NVDA), GrowGeneration (GRWG) and General Electric (GE). When did Novus Capital IPO? Novus Capital (NOVS) raised $18 million in an initial public offering (IPO) on Wednesday, May 4th 2022. The company issued 3,800,000 shares at $4.25-$5.25 per share. EF Hutton acted as the underwriter for the IPO. This page (NASDAQ:NOVS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novus Capital Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
